American Society of Hematology Announces 2017 Scholar Award Recipients
The American Society of Hematology (ASH) today announced the recipients of its 2017 Scholar Awards. One of ASH’s most prestigious award programs, the ASH Scholar Awards financially support fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.
Each Scholar Award provides up to $100,000 for fellows and $150,000 for junior faculty over a two- to three-year period. The program funds hematologists in North America who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH recognizes this year’s corporate supporters, Janssen and Incyte.
“This award has launched the careers of many independent researchers in hematology,” said ASH President Charles S. Abrams, MD, of the University of Pennsylvania. “The scholars we are supporting today have demonstrated creativity and commitment to hematology research, and I have no doubt that their studies will lead to important discoveries in our understanding of blood diseases, treatment, and patient care.”
The 2016 Scholar Awards recipients are:
Basic Research Fellows
| Grazia Abou Ezzi, PhD Washington University School of Medicine in St. Louis, MO |
Kelly Arcipowski, PhD Northwestern University Evanston, IL |
| Jeevisha Bajaj, PhD, University of California – San Diego La Jolla, CA |
Tae Kon Kim, MD, PhD Yale University New Haven, CT |
| Kellie Machlus, PhD Brigham and Women's Hospital Boston, MA |
Anna Protopopova, PhD University of Pennsylvania School of Medicine Philadelphia, PA |
| Marco Ruella, MD University of Pennsylvania Philadelphia, PA |
Zuzana Tothova, MD, PhD Dana-Farber Cancer Institute Boston, MA |
| Andrew Volk, PhD Northwestern University Evanston, IL |
Clinical Research Fellows
| Melanie Fields, MD, MSCI Washington University School of Medicine in St. Louis, MO |
| Erin Peckham-Gregory, PhD, MPH Baylor College of Medicine Houston, TX |
| Eric Smith, MD, PhD Memorial Sloan Kettering Cancer Center New York, NY |
Basic Junior Faculty
| Margarida Almeida Santos, PhD, MS, BS The University of Texas MD Anderson Cancer Center Houston, TX |
Craig Byersdorfer, MD, PhD University of Pittsburgh School of Medicine Pittsburgh, PA |
| Shuaiying Cui, PhD Boston Medical Center Boston, MA |
Jarrod Dudakov, PhD Fred Hutchinson Cancer Research Center Seattle, WA |
| Renata Grozovsky, PhD Brigham and Women's Hospital Boston, MA |
Sanggu Kim, PhD The Ohio State University Columbus, OH |
| Dan Landau, MD, PhD Weill Cornell Medicine/New York Genome Center New York, NY |
Emily Mace, PhD Baylor College of Medicine Houston, TX |
| Jeffrey Magee, MD, PhD Washington University School of Medicine in St. Louis, MO |
Christopher Ott, PhD Dana-Farber Cancer Institute Boston, MA |
| Elli Papaemmanuil, PhD Memorial Sloan Kettering Cancer Center New York, NY |
Vikram Paralkar, MD University of Pennsylvania Philadelphia, PA |
Clinical Junior Faculty
| Premal Lulla, MD Baylor College of Medicine Houston, TX |
| Alice Mims, MD, MSCR The Ohio State University Columbus, OH |
| Hong Zheng, MD, PhD The Pennsylvania State University College of Medicine Hershey, PA |
Joanne Levy, MD, Memorial Award for Outstanding Achievement
Christopher Sturgeon, PhD, of Washington University School of Medicine in St. Louis, MO, will receive the 2016 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy, MD, who passed away in 2004. It is presented to the current ASH Scholar with the highest-scoring abstract for the ASH Annual Meeting, as determined by the appointed abstract reviewers.
Dr. Sturgeon received his doctorate degree from the University of British Columbia and is currently an assistant professor in the Division of Hematology of the Department of Medicine at Washington University School of Medicine in St. Louis. He is being honored for his oral abstract (Publication #883), “Human Definitive Hematopoietic Specification from Pluripotent Stem Cells Is Regulated by Mesodermal Expression of CDX4.”
About the American Society of Hematology
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
About the ASH Foundation:
The ASH Foundation (www.hematology.org/foundation) is dedicated to moving hematology forward through support of research, career development, and quality care and education programs. The ASH Foundation is supported through funding, resources, and leadership provided by ASH, the premier organization for physicians and scientists studying and treating blood disorders, and provides a mechanism for ASH members to give in support of critical programs. Personal donations to the ASH Foundation allow the Society to do more for hematology through the expansion or enhancement of existing programs.
CONTACT:
Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925
